Concepts (180)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Arthroplasty, Replacement, Knee | 31 | 2021 | 696 | 3.460 |
Why?
|
| Arthroplasty, Replacement, Hip | 24 | 2016 | 863 | 1.800 |
Why?
|
| Knee Joint | 12 | 2016 | 797 | 1.260 |
Why?
|
| Knee Prosthesis | 13 | 2021 | 248 | 1.220 |
Why?
|
| Reoperation | 29 | 2021 | 932 | 1.000 |
Why?
|
| Minimally Invasive Surgical Procedures | 7 | 2007 | 300 | 0.830 |
Why?
|
| Prosthesis Failure | 18 | 2021 | 556 | 0.740 |
Why?
|
| Tendons | 3 | 2006 | 218 | 0.690 |
Why?
|
| Patella | 6 | 2006 | 81 | 0.640 |
Why?
|
| Osteoarthritis, Knee | 5 | 2017 | 381 | 0.630 |
Why?
|
| Prosthesis Design | 16 | 2021 | 502 | 0.580 |
Why?
|
| Femur | 8 | 2010 | 396 | 0.580 |
Why?
|
| Humans | 61 | 2021 | 29337 | 0.550 |
Why?
|
| Acetabulum | 9 | 2009 | 208 | 0.520 |
Why?
|
| Postoperative Complications | 12 | 2021 | 957 | 0.520 |
Why?
|
| Ambulatory Surgical Procedures | 2 | 2006 | 74 | 0.520 |
Why?
|
| Range of Motion, Articular | 11 | 2016 | 699 | 0.510 |
Why?
|
| Tibia | 5 | 2019 | 259 | 0.480 |
Why?
|
| Hemiarthroplasty | 1 | 2014 | 31 | 0.470 |
Why?
|
| Pain, Postoperative | 3 | 2006 | 314 | 0.450 |
Why?
|
| Treatment Outcome | 19 | 2016 | 3478 | 0.440 |
Why?
|
| Orthopedic Procedures | 4 | 2016 | 317 | 0.430 |
Why?
|
| Joint Diseases | 3 | 2016 | 110 | 0.390 |
Why?
|
| Sound Spectrography | 1 | 2010 | 10 | 0.390 |
Why?
|
| Hip Prosthesis | 9 | 2016 | 605 | 0.380 |
Why?
|
| Hip Fractures | 1 | 2010 | 32 | 0.380 |
Why?
|
| Aged | 27 | 2021 | 9448 | 0.370 |
Why?
|
| Middle Aged | 28 | 2021 | 9823 | 0.370 |
Why?
|
| Blood Loss, Surgical | 2 | 2007 | 64 | 0.360 |
Why?
|
| Recovery of Function | 8 | 2016 | 290 | 0.350 |
Why?
|
| Follow-Up Studies | 17 | 2021 | 1830 | 0.340 |
Why?
|
| Radiography | 13 | 2016 | 678 | 0.340 |
Why?
|
| Perioperative Care | 2 | 2006 | 52 | 0.330 |
Why?
|
| Male | 30 | 2021 | 15621 | 0.320 |
Why?
|
| Female | 30 | 2021 | 16197 | 0.320 |
Why?
|
| Clinical Competence | 2 | 2007 | 230 | 0.310 |
Why?
|
| Hemostasis, Surgical | 1 | 2007 | 15 | 0.310 |
Why?
|
| Electrocoagulation | 1 | 2007 | 16 | 0.310 |
Why?
|
| Polyethylenes | 1 | 2006 | 50 | 0.290 |
Why?
|
| Critical Pathways | 1 | 2006 | 21 | 0.280 |
Why?
|
| Femoral Fractures | 1 | 2006 | 41 | 0.280 |
Why?
|
| Tendon Injuries | 2 | 2005 | 196 | 0.280 |
Why?
|
| Osteolysis | 4 | 2010 | 149 | 0.270 |
Why?
|
| Bone Transplantation | 2 | 2006 | 224 | 0.270 |
Why?
|
| Cementation | 5 | 2021 | 36 | 0.260 |
Why?
|
| Hip Joint | 5 | 2016 | 367 | 0.260 |
Why?
|
| Decision Support Techniques | 1 | 2005 | 52 | 0.250 |
Why?
|
| Lactones | 1 | 2003 | 14 | 0.240 |
Why?
|
| Isoenzymes | 1 | 2003 | 50 | 0.240 |
Why?
|
| Cyclooxygenase Inhibitors | 1 | 2003 | 36 | 0.240 |
Why?
|
| Arthroscopy | 2 | 2016 | 811 | 0.240 |
Why?
|
| Arthroplasty | 1 | 2004 | 136 | 0.240 |
Why?
|
| Time Factors | 9 | 2011 | 1616 | 0.230 |
Why?
|
| Adult | 18 | 2019 | 8601 | 0.210 |
Why?
|
| Prospective Studies | 6 | 2009 | 1811 | 0.200 |
Why?
|
| Ossification, Heterotopic | 2 | 2016 | 42 | 0.200 |
Why?
|
| Osteoarthritis, Hip | 2 | 2016 | 94 | 0.180 |
Why?
|
| Transplantation, Homologous | 3 | 2005 | 277 | 0.180 |
Why?
|
| Retrospective Studies | 10 | 2019 | 3273 | 0.170 |
Why?
|
| Biomechanical Phenomena | 4 | 2017 | 668 | 0.170 |
Why?
|
| Patient Selection | 2 | 2014 | 232 | 0.160 |
Why?
|
| Knee | 1 | 2017 | 44 | 0.150 |
Why?
|
| Pain Measurement | 4 | 2016 | 462 | 0.150 |
Why?
|
| Radiotherapy | 1 | 2016 | 50 | 0.150 |
Why?
|
| Joint Instability | 3 | 2016 | 387 | 0.140 |
Why?
|
| Medial Collateral Ligament, Knee | 1 | 2016 | 7 | 0.140 |
Why?
|
| Leg Length Inequality | 1 | 2016 | 12 | 0.140 |
Why?
|
| Braces | 1 | 2016 | 26 | 0.140 |
Why?
|
| Aged, 80 and over | 11 | 2010 | 4851 | 0.140 |
Why?
|
| Intraoperative Complications | 1 | 2016 | 68 | 0.130 |
Why?
|
| Cyclooxygenase 2 Inhibitors | 2 | 2006 | 29 | 0.130 |
Why?
|
| Analgesia, Patient-Controlled | 2 | 2006 | 26 | 0.130 |
Why?
|
| Hip Dislocation | 1 | 2016 | 65 | 0.130 |
Why?
|
| Analgesia, Epidural | 2 | 2006 | 57 | 0.130 |
Why?
|
| Surgery, Computer-Assisted | 2 | 2016 | 60 | 0.120 |
Why?
|
| Posterior Cruciate Ligament | 2 | 2011 | 23 | 0.120 |
Why?
|
| Knee Injuries | 1 | 2016 | 223 | 0.120 |
Why?
|
| Education, Medical, Graduate | 1 | 2014 | 79 | 0.120 |
Why?
|
| Bone Cements | 4 | 2009 | 99 | 0.120 |
Why?
|
| Gait | 1 | 2017 | 404 | 0.120 |
Why?
|
| Risk Assessment | 4 | 2016 | 679 | 0.110 |
Why?
|
| Kaplan-Meier Estimate | 4 | 2019 | 162 | 0.110 |
Why?
|
| Orthopedics | 2 | 2005 | 127 | 0.110 |
Why?
|
| Device Removal | 3 | 2009 | 85 | 0.100 |
Why?
|
| Osteotomy | 2 | 2003 | 163 | 0.100 |
Why?
|
| Micro-Electrical-Mechanical Systems | 1 | 2010 | 1 | 0.100 |
Why?
|
| Internship and Residency | 1 | 2014 | 211 | 0.100 |
Why?
|
| Vibration | 1 | 2010 | 26 | 0.100 |
Why?
|
| Cohort Studies | 4 | 2016 | 1939 | 0.090 |
Why?
|
| Double-Blind Method | 2 | 2016 | 503 | 0.090 |
Why?
|
| Health Status Indicators | 2 | 2010 | 78 | 0.080 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2011 | 358 | 0.080 |
Why?
|
| Probability | 2 | 2004 | 94 | 0.080 |
Why?
|
| Marketing of Health Services | 1 | 2007 | 5 | 0.080 |
Why?
|
| Sodium Chloride | 1 | 2007 | 37 | 0.070 |
Why?
|
| Severity of Illness Index | 3 | 2011 | 1113 | 0.070 |
Why?
|
| Equipment Design | 1 | 2007 | 185 | 0.070 |
Why?
|
| Postoperative Period | 2 | 2019 | 288 | 0.070 |
Why?
|
| Bone Diseases | 1 | 2006 | 24 | 0.070 |
Why?
|
| Surface Properties | 1 | 2006 | 144 | 0.070 |
Why?
|
| Supine Position | 1 | 2006 | 15 | 0.070 |
Why?
|
| Clinical Protocols | 1 | 2006 | 65 | 0.070 |
Why?
|
| Education, Medical, Continuing | 1 | 2006 | 45 | 0.070 |
Why?
|
| Demography | 1 | 2006 | 77 | 0.070 |
Why?
|
| Medical Laboratory Science | 1 | 2005 | 10 | 0.070 |
Why?
|
| Feasibility Studies | 1 | 2006 | 227 | 0.070 |
Why?
|
| Nerve Block | 1 | 2006 | 62 | 0.070 |
Why?
|
| Metals | 1 | 2006 | 160 | 0.070 |
Why?
|
| Markov Chains | 1 | 2005 | 29 | 0.070 |
Why?
|
| Decision Trees | 1 | 2005 | 16 | 0.070 |
Why?
|
| Diffusion of Innovation | 1 | 2005 | 38 | 0.070 |
Why?
|
| Early Ambulation | 1 | 2004 | 20 | 0.070 |
Why?
|
| Rupture | 1 | 2004 | 115 | 0.060 |
Why?
|
| Physical Therapy Modalities | 1 | 2004 | 80 | 0.060 |
Why?
|
| Weight-Bearing | 1 | 2004 | 164 | 0.060 |
Why?
|
| Arthroplasty, Replacement | 1 | 2006 | 147 | 0.060 |
Why?
|
| Dyssomnias | 1 | 2003 | 8 | 0.060 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 1 | 2003 | 25 | 0.060 |
Why?
|
| Postoperative Nausea and Vomiting | 1 | 2003 | 18 | 0.060 |
Why?
|
| Cyclooxygenase 2 | 1 | 2003 | 30 | 0.060 |
Why?
|
| Sulfones | 1 | 2003 | 24 | 0.060 |
Why?
|
| Inhalation | 1 | 2003 | 3 | 0.060 |
Why?
|
| Osseointegration | 1 | 2003 | 76 | 0.060 |
Why?
|
| Tibial Fractures | 1 | 2003 | 13 | 0.060 |
Why?
|
| Disease Progression | 3 | 2016 | 787 | 0.060 |
Why?
|
| Sex Factors | 1 | 2004 | 496 | 0.060 |
Why?
|
| Membrane Proteins | 1 | 2003 | 173 | 0.050 |
Why?
|
| Musculoskeletal Diseases | 1 | 2003 | 41 | 0.050 |
Why?
|
| Age Factors | 1 | 2004 | 843 | 0.050 |
Why?
|
| Preoperative Care | 2 | 2016 | 135 | 0.050 |
Why?
|
| Radiotherapy Dosage | 2 | 2016 | 113 | 0.050 |
Why?
|
| Length of Stay | 1 | 2003 | 317 | 0.050 |
Why?
|
| Analgesics, Opioid | 1 | 2003 | 215 | 0.050 |
Why?
|
| Patient Satisfaction | 1 | 2003 | 295 | 0.050 |
Why?
|
| Quality of Life | 1 | 2005 | 662 | 0.050 |
Why?
|
| Risk | 1 | 2019 | 217 | 0.040 |
Why?
|
| Odds Ratio | 1 | 2019 | 285 | 0.040 |
Why?
|
| Polyethylene | 1 | 2019 | 116 | 0.040 |
Why?
|
| Equipment Failure Analysis | 2 | 2010 | 106 | 0.040 |
Why?
|
| Coated Materials, Biocompatible | 2 | 2010 | 41 | 0.040 |
Why?
|
| Spondylitis, Ankylosing | 1 | 2016 | 44 | 0.040 |
Why?
|
| Risk Adjustment | 1 | 2016 | 12 | 0.030 |
Why?
|
| Physical Examination | 1 | 2016 | 117 | 0.030 |
Why?
|
| Prosthesis Fitting | 1 | 2016 | 22 | 0.030 |
Why?
|
| Intraoperative Care | 1 | 2016 | 44 | 0.030 |
Why?
|
| Patient Reported Outcome Measures | 1 | 2019 | 379 | 0.030 |
Why?
|
| Postoperative Care | 1 | 2016 | 127 | 0.030 |
Why?
|
| Muscle, Skeletal | 1 | 2017 | 349 | 0.030 |
Why?
|
| Survival Analysis | 2 | 2005 | 298 | 0.030 |
Why?
|
| Health Care Costs | 2 | 2004 | 70 | 0.030 |
Why?
|
| Osteoarthritis | 1 | 2016 | 363 | 0.030 |
Why?
|
| Risk Factors | 2 | 2010 | 2443 | 0.020 |
Why?
|
| Polymethacrylic Acids | 1 | 2010 | 5 | 0.020 |
Why?
|
| Illinois | 1 | 2010 | 241 | 0.020 |
Why?
|
| Patellofemoral Joint | 1 | 2010 | 52 | 0.020 |
Why?
|
| United States | 2 | 2006 | 2333 | 0.020 |
Why?
|
| Regression Analysis | 1 | 2009 | 298 | 0.020 |
Why?
|
| Leukocyte Count | 1 | 2007 | 92 | 0.020 |
Why?
|
| Blood Sedimentation | 1 | 2007 | 64 | 0.020 |
Why?
|
| C-Reactive Protein | 1 | 2007 | 125 | 0.020 |
Why?
|
| Synovial Fluid | 1 | 2007 | 123 | 0.020 |
Why?
|
| Pelvic Bones | 1 | 2006 | 20 | 0.020 |
Why?
|
| Prosthesis-Related Infections | 1 | 2009 | 214 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2007 | 553 | 0.020 |
Why?
|
| Orthopedic Equipment | 1 | 2005 | 7 | 0.020 |
Why?
|
| Technology Assessment, Biomedical | 1 | 2005 | 5 | 0.020 |
Why?
|
| United States Food and Drug Administration | 1 | 2005 | 70 | 0.020 |
Why?
|
| Porosity | 1 | 2004 | 71 | 0.020 |
Why?
|
| Contraindications | 1 | 2004 | 41 | 0.020 |
Why?
|
| Sampling Studies | 1 | 2003 | 28 | 0.020 |
Why?
|
| Bone Wires | 1 | 2003 | 13 | 0.010 |
Why?
|
| Cost-Benefit Analysis | 1 | 2004 | 144 | 0.010 |
Why?
|
| Statistics, Nonparametric | 1 | 2003 | 138 | 0.010 |
Why?
|
| Chi-Square Distribution | 1 | 2003 | 145 | 0.010 |
Why?
|
| Incidence | 1 | 2006 | 756 | 0.010 |
Why?
|
| Intraoperative Period | 1 | 2003 | 29 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 2003 | 364 | 0.010 |
Why?
|
| Surgical Flaps | 1 | 2003 | 49 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2003 | 394 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2006 | 1221 | 0.010 |
Why?
|